EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

AIDS-related non-Hodgkin's lymphomas: From pathology and molecular pathogenesis to treatment



AIDS-related non-Hodgkin's lymphomas: From pathology and molecular pathogenesis to treatment



Human Pathology 33(4): 392-404, April



In the highly active antiretroviral therapy (HAART) era, AIDS-related non-Hodgkin's lymphomas (AIDS-NHL) and their treatment still represent an open issue, because HAART may not be sufficient to prevent the development of NHL. The present spectrum of AIDS-NHL includes systemic lymphomas, primary central nervous system lymphomas, and 2 rare entities, primary effusion lymphomas (PEL) and plasmablastic lymphomas of the oral cavity. The vast majority of systemic AIDS-NHL belongs to 3 high-grade B-cell lymphomas: Burkitt's lymphoma (BL), immunoblastic: lymphoma (IBL), and large-cell lymphoma (LCL). The pathologic heterogeneity of AIDS-NHL is correlated with the heterogeneity of the molecular lesions associated with these lymphomas. The molecular lesions associated with AIDS-BL involve activation of c-MYC inactivation of p53, and infection by Epstein-Barr virus (EBV). EBV infection occurs in 40% of LCL cases and in 90% of IBL cases. Rearrangements of BCL-6 are detected in 20% of AIDS-LCL cases. In the presence of EBV infection, BCL-6 expressing AIDS-LCL fails to express the latent membrane protein 1 (LMP1) antigen. Conversely, AIDS-IBL are characterized by absent BCL-6 expression, absence of BCL-6 rearrangements, and frequent expression of LMP1. Consistently, the molecular pathways of viral infection and lesions of cancer-related genes associated with AIDS-NHL vary substantially in different clinicopathologic categories of the disease. The marked degree of biologic heterogeneity of AIDS-NHL is highlighted by their histogenetic differences, because AIDS-NHL are related to distinct B cell subsets (ie, germinal center (GC) or post-GC B cells). The phenotypic pattern of AIDS-BL and systemic AIDS-LCL closely reflects B cells residing in the GC, namely centroblasts and centrocytes. Conversely, the phenotype of AIDS-IBL, either systemic or localized primarily to the central nervous system, and AIDS-PEL reflects post-GC B cells in all cases. New information on the molecular and virologic pathogenesis of AIDS-NHL may serve as a point of attack for pathogenic-driven therapies. Moreover, a greater knowledge of other biologic features of these tumors may help investigators identify new potential targets for "intelligent" therapies.

(PDF emailed within 0-6 h: $19.90)

Accession: 010108181

Download citation: RISBibTeXText

PMID: 12055673

DOI: 10.1053/hupa.2002.124723



Related references

Hodgkin lymphomas in HIV/AIDS patients when treated with combined antiretroviral therapy: further studies are needed for understanding the pathogenesis of developing Hodgkin lymphomas in HIV. Revista Da Sociedade Brasileira de Medicina Tropical 46(3): 385-386, 2014

AIDS-related lymphomas: from pathogenesis to pathology. British Journal of Haematology 90(2): 235-243, 1995

AIDS-related lymphomas: from pathogenesis to pathology. British Journal of Haematology 130(5): 662-670, 2005

Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: Implications for disease pathogenesis. Human Pathology 33(7): 723-731, July, 2002

Molecular pathogenesis of AIDS-related lymphomas. Advances in Cancer Research 67: 113-153, 1995

Molecular pathogenesis of AIDS-related lymphomas. Antibiotics and ChemoTherapy 46: 117-124, 1994

Molecular pathology of AIDS-related lymphomas. Annals of Hematology 69(6): 281-290, 1994

AIDS-related B-cell non-Hodgkin's lymphomas in direct blood-stream HIV-infected patients: pathogenesis and differentiation features. International Journal of Cancer 45(5): 883-888, 1990

Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity. American Journal of Pathology 152(3): 623-630, 1998

Molecular pathology in the diagnosis and treatment of non-Hodgkin's lymphomas. Journal of Cellular and Molecular Medicine 7(4): 494-512, 2003

Molecular pathology in the diagnosis and treatment of non-Hodgkin's lymphomas. Journal of Cellular and Molecular Medicine 7(4): 494-512, 2004

AIDS-related non-Hodgkin's lymphomas: molecular genetics, viral infection and cytokine deregulation. Acta Haematologica 95(3-4): 193-198, 1996

Correlative morphologic and molecular genetic analysis of 75 AIDS-related systemic non-Hodgkin lymphomas. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 14(4): A50, 1997

Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity. Annals of Hematology 69(6): 281-290, 1994

Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol. European Journal of Haematology 54(2): 73-77, 1995